Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their chances for use in drugs, raises $300M Series B (Daniel McCoy/Wichita Business Journal)
Daniel McCoy / Wichita Business Journal: Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their chances for use in drugs, raises $300M Series B — A Boston-based…
Read more »